Finally, we may have the perfect paper that illustrates the critical difference between overall mortality rates and cancer-specific cancer rates among men with prostate cancer, and how affecting one may have no effect whatsoever on the other! … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: diet, mortality, nuts, overall, prostate cancer-specific, survival | 2 Comments »
Probably because of high level of research funding as a consequence of the Movember Foundation‘s initiatives, Australia is increasingly providing us with interesting data on the diagnosis, management, and outcomes of men with prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: Diagnosis, mortality, outcome, overall, prostate cancer-specific, PSA, risk | 105 Comments »
An article just published in the World Journal of Urology has suggested that rates of prostate cancer-specific mortality in Australia seem to have been unexpectedly higher than in the USA. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: Australia, mortality, prostate cancer-specific, rate, risk | Leave a comment »
An open-access, full text article in the April issue of the Journal of Urology addresses long-standing questions about the impact of regular aspirin use on the long-term outcomes of men diagnosed with and treated for prostate cancer. … READ MORE
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: anti-inflammatory, aspirin, mortality, overall, prostate cancer-specific | 2 Comments »
The issue of how long a man who is newly diagnosed with localized prostate cancer is likely to live before he dies a natural death from other causes is a crucial element in the decision whether to undergo treatment (and how aggressive that treatment may need to be). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: mortality, non-prostate cancer-specific, outcome, overall, prostate cancer-specific, risk | 6 Comments »
According to a media release issued by the European Association of Urology on Saturday, just prior to the opening of their annual meeting in Milan, Italy, “Surgery is superior to radiotherapy in men with localized [prostate cancer].” This headline is not even justifiable based on the content of the media release. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: outcome, overall, prostate cancer-specific, radiation, risk, surgery, Sweden | 2 Comments »
A new analysis of information from the Surveillance, Epidemiology and End Results (SEER) database suggests that the “hazard” for prostate cancer-specific mortality after radical prostatectomy is very low but that it does increase in a continuous manner for at least 15 years post-treatment. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: hazard, mortality, PCSM, prostate cancer-specific, radical prostatectomy, surgery | 6 Comments »
A fascinating new paper based on data from the Prostate Cancer DataBase Sweden provides important insight into the consequences of delayed diagnosis and potential under-treatment of men who are diagnosed with locally advanced prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: delayed, Diagnosis, locally advanced, mortality, prostate cancer-specific | 14 Comments »
An article in Progrès en urologie states that the prostate cancer-specific mortality rate in France has been dropping by 2.5 percent per year. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: France, mortality, prostate cancer-specific | 1 Comment »
As a follow-up to our earlier post on this topic, we have now identified the original media release issued by Kings College London and the UK’s National National Cancer Intelligence Network (NCIN) on which today’s article in The Daily Telegraph (and other media) was based. That article clearly stated that up to 49 percent of men diagnosed with prostate cancer were dying from this disorder. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: mortality, prostate cancer-specific, UK, United Kingdom | 11 Comments »
A report in The Daily Telegraph today states that “experts at King’s College London have now found the proportion of men with prostate cancer who actually die from it to be higher than previously thought.” Supposedly, the new research finding is that for 49 percent of 20,000 men diagnosed between 1997 and 2007 “prostate cancer was the principal cause of death.” … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: mortality, prostate cancer-specific, UK, United Kingdom | 7 Comments »
With the failure of Combidex (ferumoxtran-10) to achieve FDA approval as an imaging agent for lymph node-positive prostate cancer and the recognized limitations of the ProstaScint (capromab pendetide) scan, there is a widely acknowledged need for a much more specific and accurate prostate cancer imaging agent than anything currently available. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: Endocyte, imaging, prostate cancer-specific, Purdue | Leave a comment »
A new analysis of information from the Swedish national prostate cancer registry database and the Swedish cause of death register has confirmed the importance of aggressive, curative treatment of men with locally advanced prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: locally advanced, mortality, prostate cancer-specific, Sweden | 1 Comment »
One of the most complicated questions in dealing with prostate cancer is correctly assessing whether men who are known to have had prostate cancer actually died of their prostate cancer or simply with it, especially among men of more advanced age or with co-morbid conditions. In other words, “What do prostate cancer patients die of?” … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: cause, death, mortality, prostate cancer-specific, risk | 9 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 